Company / Operating Cash Flow
MIMEDX GROUP, INC. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$74.0M
FY2025
5-year range
-$17.9M / $74.0M
FY2021-FY2025
Trend
+11.8%
vs FY2024
Sector context
#112 of 159
Health Care
What the data says
At $74M, MIMEDX GROUP, INC.'s operating cash flow ranks #112 of 159 in the Health Care sector. Operating Cash Flow has increased for 3 consecutive years, from -$18M in FY2022 to $74M in FY2025.
Based on SEC 10-K filings.
$74M in FY2025.
Improved from $27M to $74M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#112 of 159 in Health CareTop 70% of 159This company $74.0M Sector average $1.0B
▼
-92.8% below sector average
Key checks
Key Insights
- MIMEDX GROUP, INC.'s operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 11.8% year-over-year.
- Ranks #112 out of 159 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.50 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $74.0M | +11.8% |
| FY2024 | $66.2M | +147.2% |
| FY2023 | $26.8M | +249.6% |
| FY2022 | -$17.9M | -802.8% |
| FY2021 | -$2.0M | +93.5% |
| FY2020 | -$30.3M | +23.2% |
| FY2019 | -$39.4M | -210.1% |
| FY2018 | $35.8M | -43.1% |
| FY2017 | $62.9M | +163.9% |
| FY2016 | $23.8M | +26.8% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026